Combination of midbrain-to-pontine ratio and cardiac MIBG scintigraphy to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy

Combination of midbrain-to-pontine ratio and cardiac MIBG scintigraphy to differentiate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy

Background: An early clinical differentiation between Parkinson's disease (PD) and multiple system atrophy (MSA) or progressive supranuclear palsy (PSP) remains a challenge. The purpose of this study was to evaluate the usefulness of the combination use of midbrain-to-pontine ratio (M/P ratio)...

Full description

Bibliographic Details
Main Authors:	Hirotaka Sakuramoto, Hiroaki Fujita, Keisuke Suzuki, Takeo Matsubara, Yuji Watanabe, Mai Hamaguchi, Koichi Hirata
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	Clinical Parkinsonism & Related Disorders
Subjects:	Parkinson's disease Multiple system atrophy Progressive supranuclear palsy MRI methodology Midbrain-to-pontine ratio Cardiac 123I-metaiodobenzylguanidine (MIBG) scintigraphy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590112519300337

Similar Items

Clinical perspectives of using scintigraphy with 123-1-MIBG for assessment of sympathetic nervous system of the myocardium
by: I V Sergienko, et al.
Published: (2003-04-01)

The significance of metaiodobenzylguanidine scintigraphy in the treatment of high risk neuroblastomas
by: Nikolić Katarina, et al.
Published: (2020-01-01)

Sympathetic Dysautonomia in Heart Failure by 123I-MIBG: comparison between Chagasic, non-Chagasic and heart transplant patients
by: Viviane Santuari Parisotto Marino, et al.
Published: (2018-08-01)

The potential role of the cardiac MIBG scan in differentiating the drug-induced Parkinsonism from Parkinson’s disease
by: Mahan Shafie, et al.
Published: (2022-01-01)

Massive pheochromocytoma
by: Terumitsu Anai, et al.
Published: (2020-11-01)

Power spectral analysis of heart rate variability is useful as a screening tool for detecting sympathetic and parasympathetic nervous dysfunctions in Parkinson’s disease
by: Tomo Miyagi, et al.
Published: (2022-09-01)

NEUROTROPIC MYOCARDIAL SCINTIGRAPHY IN THE EVALUATION OF SUDDEN CARDIAC DEATH PROGNOSIS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
by: A. A. Ansheles, et al.
Published: (2017-09-01)

Standardization of 123I-metaiodobenzylguanidine cardiac neurotropic scintigraphy and single-photon emission tomography
by: A. A. Ansheles, et al.
Published: (2016-07-01)

The potential for early diagnosis of pulmonary arterial hypertension using lung iodine-123-metaiodobenzylguanidine (123I-MIBG) uptake: A case report
by: Kenjuro Higo, MDPhD, et al.
Published: (2020-08-01)

Hummingbird sign in progressive supranuclear palsy disease
by: Sanjay Pandey
Published: (2012-01-01)

Utility of 123I-MIBG Standardized Uptake Value in Patients with Refractory Pheochromocytoma and Paraganglioma
by: Hiroshi Wakabayashi, et al.
Published: (2019-06-01)

The Prognostic Value of the Results of <sup>123</sup>I-metaiodobenzylguanidine Myocardial Scintigraphy in the Examination of Patients with Atrial Fibrillation Referred for Its Interventional Treatment
by: Yu. V. Varlamova, et al.
Published: (2019-11-01)

Cardiac sympathetic denervation could be associated with dysphagia in Parkinson's disease
by: Jinyoung Youn, et al.
Published: (2022-10-01)

Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson’s disease
by: Cecilia Boccalini, et al.
Published: (2022-12-01)

Thyroid [123I]MIBG uptake in Parkinson’s disease and diabetes mellitus
by: Tatyana D. Fedorova, et al.
Published: (2023-06-01)

Diagnostic Use of Post-therapy <sup>131</sup>I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma
by: Hiroshi Wakabayashi, et al.
Published: (2020-09-01)

“Penguin” or “Hummingbird” Sign and Midbrain Atrophy in Progressive Supranuclear Palsy
by: Pelin Nar, et al.
Published: (2010-12-01)

“Penguin” or “Hummingbird” Sign and Midbrain Atrophy in Progressive Supranuclear Palsy
by: Pelin Nar, et al.
Published: (2010-12-01)

Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson’s Disease: A Multicenter Study
by: Maria Silvia De Feo, et al.
Published: (2023-08-01)

Cardiac Autonomic Dysfunction Is Associated with Severity of REM Sleep without Atonia in Isolated REM Sleep Behavior Disorder
by: Sooyeoun You, et al.
Published: (2021-11-01)

Cardiac 131I-MIBG scintigraphy in patients with multiple system atrophy
by: Li WANG, et al.
Published: (2014-03-01)

Erratum: Manual and semi-automated approaches to MIBG myocardial scintigraphy in patients with Parkinson's disease
by: Frontiers Production Office
Published: (2023-03-01)

Dynamic planar scintigraphy for the rapid kinetic measurement of myocardial 123I-MIBG turnover can identify Lewy body disease
by: Yoshitaka Kumakura, et al.
Published: (2021-12-01)

Methods and utility of quantitative brainstem measurements in progressive supranuclear palsy versus Parkinson's disease in a routine clinical setting
by: Jessica Cooperrider, et al.
Published: (2020-01-01)

QUANTITATIVE APPROACH TO ASSIST NEUROBLASTOMA ASSESSMENT BY MEASURING I-123 mIBG UPTAKE IN SCINTIGRAPHIC IMAGES
by: Rafael Martínez-Díaz, et al.
Published: (2015-03-01)

Atypical Presentation of an Adrenal Mass
by: KRISHNA SWATHI PAVULURI, et al.
Published: (2021-05-01)

I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review
by: Eun Joo Chung, et al.
Published: (2015-05-01)

Renal <sup>123</sup>I-MIBG Uptake before and after Live-Donor Kidney Transplantation
by: Thomas Rasmussen, et al.
Published: (2020-10-01)

Uptake index of 123I-metaiodobenzylguanidine myocardial scintigraphy for diagnosing Lewy body disease
by: Yoshito Kamiya, et al.
Published: (2017-01-01)

Body mass index and severity of parkinsonism in multiple system atrophy
by: Ai Suzuki, et al.
Published: (2017-09-01)

Potential Utility of 123I-MIBG Scintigraphy as a Predictor of Falls in Parkinson's Disease
by: Nagahisa Murakami, et al.
Published: (2019-04-01)

High clinical diagnostic accuracy of combined salivary gland and myocardial metaiodobenzylguanidine scintigraphy in the diagnosis of Parkinson’s disease
by: Shuangfang Li, et al.
Published: (2023-01-01)

Biological Distribution of Orally Administered [<sup>123</sup>I]MIBG for Estimating Gastrointestinal Tract Absorption
by: Masato Kobayashi, et al.
Published: (2021-12-01)

Takotsubo syndrome in a heart transplant recipient with poor cardiac sympathetic reinnervation
by: Ryo Miyake, et al.
Published: (2020-06-01)

Azelnidipine is a useful medication for the treatment of heart failure preserved ejection fraction
by: Shunsuke Kiuchi, et al.
Published: (2017-05-01)

Accumulation of 123I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson’s Disease
by: Hidetomo Murakami, et al.
Published: (2017-09-01)

MIBG Therapy for Neuroblastoma: Precision Achieved With Dosimetry, and Concern for False Responders
by: Pedro M. Rubio, et al.
Published: (2020-05-01)

A Case of <sup>123</sup>I-Metaiodobenzylguanidine Scintigraphy-Negative Pheochromocytoma with a Tumor-Developing Mutation in the <i>RET</i> Gene
by: Haremaru Kubo, et al.
Published: (2022-08-01)

Radioterapia interna con metayodobencilguanidina 131I-MIBG
by: Harold Machado, et al.
Published: (2002-07-01)

LC3/FtMt Colocalization Patterns Reveal the Progression of FtMt Accumulation in Nigral Neurons of Patients with Progressive Supranuclear Palsy
by: Zulzikry Hafiz Abu Bakar, et al.
Published: (2022-01-01)